Advanced search
Publication Cover
International Reviews of Immunology Volume 30, 2011 - Issue 2-3
Submit an article Journal homepage
954
Views
82
CrossRef citations to date
0
Altmetric
Research Article

Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines

Cheryl Lai-Lai ChiangOvarian Cancer Research Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
,
Lana E. KandalaftOvarian Cancer Research Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
&
George CoukosOvarian Cancer Research Center, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USACorrespondence[email protected]
Pages 150-182 | Published online: 10 May 2011

Citations (82)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Victor I. Seledtsov & Alexei von Delwig. (2021) Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer. Expert Opinion on Biological Therapy 21:3, pages 323-342.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now
Matthias Schröder, Simone Loos, Svenja Kerstin Naumann, Christopher Bachran, Marit Krötschel, Viktor Umansky, Laura Helming & Lee Kim Swee. (2017) Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening. OncoImmunology 6:1.
Read now
Katherine A Murphy, Britnie R James, Yue Guan, Donald S Torry, Andrew Wilber & Thomas S Griffith. (2015) Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma. Human Vaccines & Immunotherapeutics 11:7, pages 1612-1620.
Read now
Cheryl Lai-Lai Chiang, Klara Balint, George Coukos & Lana E Kandalaft. (2015) Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opinion on Biological Therapy 15:4, pages 569-582.
Read now
VI Seledtsov, AG Goncharov & GV Seledtsova. (2015) Clinically feasible approaches to potentiating cancer cell-based immunotherapies. Human Vaccines & Immunotherapeutics 11:4, pages 851-869.
Read now
Mohan Karkada, Neil L Berinstein & Marc Mansour. (2014) Therapeutic vaccines and cancer: focus on DPX-0907. Biologics: Targets and Therapy 8, pages 27-38.
Read now
Laetitia Cicchelero, Hilde de Rooster & Niek N Sanders. (2014) Various ways to improve whole cancer cell vaccines. Expert Review of Vaccines 13:6, pages 721-735.
Read now
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Francesca Kalli, Maurizio Zanetti & Gilberto Filaci. (2013) Generation of more effective cancer vaccines. Human Vaccines & Immunotherapeutics 9:12, pages 2543-2547.
Read now
David A Reardon, Kai W Wucherpfennig, Gordon Freeman, Catherine J Wu, E Antonio Chiocca, Patrick Y Wen, William T Curry$suffix/text()$suffix/text(), Duane A Mitchell, Peter E Fecci, John H Sampson & Glenn Dranoff. (2013) An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Review of Vaccines 12:6, pages 597-615.
Read now
Jian Y. Cheng & Ratnavelu Kananathan. (2012) CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma. Human Vaccines & Immunotherapeutics 8:12, pages 1799-1801.
Read now
Gina M. Mantia-Smaldone, Bradley Corr & Christina S. Chu. (2012) Immunotherapy in ovarian cancer. Human Vaccines & Immunotherapeutics 8:9, pages 1179-1191.
Read now

Articles from other publishers (69)

Jiaqi Meng, Yanlin Lv, Weier Bao, Zihui Meng, Shuang Wang, Yuanbin Wu, Shuping Li, Zhouguang Jiao, Zhiyuan Tian, Guanghui Ma & Wei Wei. (2023) Generation of whole tumor cell vaccine for on-demand manipulation of immune responses against cancer under near-infrared laser irradiation. Nature Communications 14:1.
Crossref
Manasa Manjunath Hegde, Puja Sandbhor, Aishwarya J.Vikram Gota & Jayant S. Goda. (2023) Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. Frontiers in Oncology 13.
Crossref
Yuan Ding, Jiali Yang, Huiye Wei, Jiachen Wang, Sicong Huang, Shuguang Yang, Yu Guo, Bo Li & Xintao Shuai. (2023) Construction of pH‐Sensitive Nanovaccines Encapsulating Tumor Cell Lysates and Immune Adjuvants for Breast Cancer Therapy. Small.
Crossref
Yahya Alhamhoom, Greeshma Kakinani, Mohamed Rahamathulla, Riyaz Ali M. Osmani, Umme Hani, Kamal Yoonus Thajudeen, G. Kiran Raj & Devegowda V. Gowda. (2023) Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review. Saudi Pharmaceutical Journal 31:2, pages 279-294.
Crossref
Victor Ivanovich Seledtsov, Adas Darinskas, Alexei Von Delwig & Galina Victorovna Seledtsova. (2023) Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 13:1, pages 123.
Crossref
Huju Chi, Yue Hao, Xia Wang, Li Tang, Yongqiang Deng, Xianxiong Chen, Feng Gao, Ou Sha & Guangyi Jin. (2022) A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist. Cells 11:13, pages 1986.
Crossref
V. I. Seledtsov, G. V. Seledtsova, A. B. Dorzhieva & I. P. Ivanova. (2022) Immunotherapy in the complex treatment of tumor diseases. Siberian journal of oncology 21:2, pages 118-129.
Crossref
Ridhima Jasrotia, Daljeet Singh Dhanjal, Sonali Bhardwaj, Parvarish Sharma, Chirag Chopra, Reena Singh, Anupam Kumar, Anamika Mubayi, Deepak Kumar, Raj Kumar & Abhineet Goyal. (2022) Nanotechnology based vaccines: Cervical cancer management and perspectives. Journal of Drug Delivery Science and Technology 71, pages 103351.
Crossref
Olaia Akesolo, Berta Buey, Manuel Beltrán-Visiedo, David Giraldos, Isabel Marzo & Eva Latorre. (2022) Toll-like receptors: New targets for multiple myeloma treatment?. Biochemical Pharmacology 199, pages 114992.
Crossref
Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei & Xiawei Wei. (2022) Cancer vaccines as promising immuno-therapeutics: platforms and current progress. Journal of Hematology & Oncology 15:1.
Crossref
Zhouqi Meng, Yaojia Zhang, Xuanfang Zhou, Jiansong Ji & Zhuang Liu. (2022) Nanovaccines with cell-derived components for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114107.
Crossref
Cristiana Berti, Alice Boarino, Michele Graciotti, Lisa P. E. Bader, Lana E. Kandalaft & Harm-Anton Klok. (2021) Reduction-Sensitive Protein Nanogels Enhance Uptake of Model and Tumor Lysate Antigens In Vitro by Mouse- and Human-Derived Dendritic Cells. ACS Applied Bio Materials 4:12, pages 8291-8300.
Crossref
Mei-Zhen Zou, Zi-Hao Li, Xue-Feng Bai, Chuan-Jun Liu & Xian-Zheng Zhang. (2021) Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy. Nano Letters 21:20, pages 8609-8618.
Crossref
Divya Nagarajan, Joshua Pearson, Victoria Brentville, Rachael Metheringham, A Graham Pockley, Lindy Durrant & Stephanie E McArdle. (2021) Helicase antigen (HAGE)‐derived vaccines induce immunity to HAGE and ImmunoBody®‐HAGE DNA vaccine delays the growth and metastasis of HAGE‐expressing tumors in vivo . Immunology & Cell Biology 99:9, pages 972-989.
Crossref
Tong Ye, Feng Li, Guanghui Ma & Wei Wei. (2021) Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors. Advanced Drug Delivery Reviews 177, pages 113927.
Crossref
Benqing Zhou, Jinxing Liu, Meiai Lin, Jingyi Zhu & Wei R. Chen. (2021) Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy. Coordination Chemistry Reviews 442, pages 214009.
Crossref
Courtney T. Stump, Gregory Ho, Chenkai Mao, Frank A. Veliz, Veronique Beiss, Jennifer Fields, Nicole F. Steinmetz & Steven Fiering. (2021) Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth. Cancers 13:4, pages 627.
Crossref
Apostolos Sarivalasis, Matteo Morotti, Arthur Mulvey, Martina Imbimbo & George Coukos. (2021) Cell therapies in ovarian cancer. Therapeutic Advances in Medical Oncology 13, pages 175883592110083.
Crossref
Tilahun Ayane Debele, Cheng-Fa Yeh & Wen-Pin Su. (2020) Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators. Cancers 12:12, pages 3773.
Crossref
Yizhao Han, Zhuojun Liu, Jia Liu, Weiqi Yan, Yuanshi Xia, Shuhua Yue & Jian Yu. (2020) Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies. BioMed Research International 2020, pages 1-8.
Crossref
Beiu, Giurcaneanu, Grumezescu, Holban, Popa & Mihai. (2020) Nanosystems for Improved Targeted Therapies in Melanoma. Journal of Clinical Medicine 9:2, pages 318.
Crossref
Logan Corey, Ana Valente & Katrina Wade. (2020) Personalized Medicine in Gynecologic Cancer. Surgical Oncology Clinics of North America 29:1, pages 105-113.
Crossref
Jiayun Yu, Bin Shao, Min Luo, Wei Du, Wen Nie, Jingyun Yang & Xiawei Wei. (2020) Irradiated lactic acid-stimulated tumour cells promote the antitumour immunity as a therapeutic vaccine. Cancer Letters 469, pages 367-379.
Crossref
Emad Matanes & Walter H. Gotlieb. (2019) Immunotherapy of gynecological cancers. Best Practice & Research Clinical Obstetrics & Gynaecology 60, pages 97-110.
Crossref
Xiaoli Wang, Zuoguan Chen, Chao Zhang, Chuangnian Zhang, Guilei Ma, Jing Yang, Xiaoqing Wei & Hongfan Sun. (2019) A Generic Coordination Assembly‐Enabled Nanocoating of Individual Tumor Cells for Personalized Immunotherapy. Advanced Healthcare Materials 8:17, pages 1900474.
Crossref
Stephen Jiang, David Good & Ming Q. Wei. (2019) Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants. International Journal of Molecular Sciences 20:14, pages 3403.
Crossref
Xiaoli Wang, Ning Wang, Ying Yang, Xiaoxiao Wang, Jiayi Liang, Xinxin Tian, Hailing Zhang & Xigang Leng. (2019) Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomaterials Science 7:7, pages 3062-3075.
Crossref
Flavia Fontana, Manlio Fusciello, Christianne Groeneveldt, Cristian Capasso, Jacopo Chiaro, Sara Feola, Zehua Liu, Ermei M. Mäkilä, Jarno J. Salonen, Jouni T. Hirvonen, Vincenzo Cerullo & Hélder A. Santos. (2019) Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor. ACS Nano 13:6, pages 6477-6490.
Crossref
Logan Corey, Ana Valente & Katrina Wade. (2019) Personalized Medicine in Gynecologic Cancer. Obstetrics and Gynecology Clinics of North America 46:1, pages 155-163.
Crossref
Xiaoli Wang, Jiayi Liang, Chuangnian Zhang, Guilei Ma, Chun Wang & Deling Kong. (2019) Coordination microparticle vaccines engineered from tumor cell templates. Chemical Communications 55:11, pages 1568-1571.
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy 45 59 .
Marc J. Braunstein, John Kucharczyk & Sylvia Adams. (2018) Targeting Toll-Like Receptors for Cancer Therapy. Targeted Oncology 13:5, pages 583-598.
Crossref
Elias Sayour, Hector Mendez-Gomez & Duane Mitchell. (2018) Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes. International Journal of Molecular Sciences 19:10, pages 2890.
Crossref
Jingwei Ma, Keke Wei, Huafeng Zhang, Ke Tang, Fei Li, Tianzhen Zhang, Junwei Liu, Pingwei Xu, Yuandong Yu, Weiwei Sun, LiYan Zhu, Jie Chen, Li Zhou, Xiaoyu Liang, Jiadi Lv, Roland Fiskesund, Yuying Liu & Bo Huang. (2018) Mechanisms by Which Dendritic Cells Present Tumor Microparticle Antigens to CD8+ T Cells. Cancer Immunology Research 6:9, pages 1057-1068.
Crossref
Nafiseh Pakravan & Zuhair Mohammad Hassan. (2018) Immunotherapy using regulatory T cells in cancer suggests more flavors of hypersensitivity type IV. Immunotherapy 10:3, pages 213-219.
Crossref
Charles B Chesson & Andrew Zloza. (2017) Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer. Nanomedicine 12:23, pages 2693-2706.
Crossref
Abhishek D. Garg & Patrizia Agostinis. (2017) Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. Immunological Reviews 280:1, pages 126-148.
Crossref
Jun Xie, Chaohua Yang, Qianqian Liu, Jun Li, Ruijing Liang, Chen Shen, Yi Zhang, Ke Wang, Liping Liu, Khurram Shezad, Martin Sullivan, Yong Xu, Guanxin Shen, Juan Tao, Jintao Zhu & Zhiping Zhang. (2017) Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response. Small 13:40, pages 1701741.
Crossref
Shuyun Dong, Tiefeng Xu, Peng Wang, Peng Zhao & Mingnan Chen. (2017) Engineering of a self-adjuvanted iTEP-delivered CTL vaccine. Acta Pharmacologica Sinica 38:6, pages 914-923.
Crossref
Hiep Khong & Willem W. Overwijk. (2016) Adjuvants for peptide-based cancer vaccines. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Eleni Maria Varypataki, Ana Luisa Silva, Christophe Barnier-Quer, Nicolas Collin, Ferry Ossendorp & Wim Jiskoot. (2016) Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles. Journal of Controlled Release 226, pages 98-106.
Crossref
M-C Chang, Y-L Chen, Y-C Chiang, T-C Chen, Y-C Tang, C-A Chen, W-Z Sun & W-F Cheng. (2015) Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator. Gene Therapy 23:1, pages 38-49.
Crossref
V.I. Seledtsov, A.G. Goncharov & G.V Seledtsova. (2015) Multiple-purpose immunotherapy for cancer. Biomedicine & Pharmacotherapy 76, pages 24-29.
Crossref
Abhishek D. Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B. Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone, An Coosemans, Pierre G. Coulie, Dirk De Ruysscher, Luciana Dini, Peter de Witte, Aleksandra M. Dudek-Peric, Alberto Faggioni, Jitka Fucikova, Udo S. Gaipl, Jakub Golab, Marie-Lise Gougeon, Michael R. Hamblin, Akseli Hemminki, Martin Herrmann, James W. Hodge, Oliver Kepp, Guido Kroemer, Dmitri V. Krysko, Walter G. Land, Frank Madeo, Angelo A. Manfredi, Stephen R. Mattarollo, Christian Maueroder, Nicolò Merendino, Gabriele Multhoff, Thomas Pabst, Jean-Ehrland Ricci, Chiara Riganti, Erminia Romano, Nicole Rufo, Mark J. Smyth, Jürgen Sonnemann, Radek Spisek, John Stagg, Erika Vacchelli, Peter Vandenabeele, Lien Vandenberk, Benoit J. Van den Eynde, Stefaan Van Gool, Francesca Velotti, Laurence Zitvogel & Patrizia Agostinis. (2015) Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology 6.
Crossref
Meihua Chen, Rong Xiang, Yuan Wen, Guangchao Xu, Chunting Wang, Shuntao Luo, Tao Yin, Xiawei Wei, Bin Shao, Ning Liu, Fuchun Guo, Meng Li, Shuang Zhang, Minmin Li, Kexing Ren, Yongsheng Wang & Yuquan Wei. (2015) A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts. Scientific Reports 5:1.
Crossref
K. Dietrich & M. Theobald. (2015) Immunologische TumortherapieImmunological tumor therapy. Der Internist 56:8, pages 907-917.
Crossref
Cheryl Chiang, George Coukos & Lana Kandalaft. (2015) Whole Tumor Antigen Vaccines: Where Are We?. Vaccines 3:2, pages 344-372.
Crossref
Duane A. Mitchell, Elias J. Sayour, Elizabeth Reap, Robert Schmittling, Gabriel DeLeon, Pamela Norberg, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, Gary Archer & John H. Sampson. (2015) Severe Adverse Immunologic Reaction in a Patient with Glioblastoma Receiving Autologous Dendritic Cell Vaccines Combined with GM-CSF and Dose-Intensified Temozolomide. Cancer Immunology Research 3:4, pages 320-325.
Crossref
Amani Makkouk & George J. Weiner. (2015) Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge. Cancer Research 75:1, pages 5-10.
Crossref
Maria Libera Ascierto, Salvador Martin Algarra, Ignacio Melero & Paolo A. Ascierto. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies 245 258 .
D. A. Reardon, G. Freeman, C. Wu, E. A. Chiocca, K. W. Wucherpfennig, P. Y. Wen, E. F. Fritsch, W. T. Curry, J. H. Sampson & G. Dranoff. (2014) Immunotherapy advances for glioblastoma. Neuro-Oncology 16:11, pages 1441-1458.
Crossref
H. Liang, L. Yi, X. Wang, C. Zhou & L. Xu. (2014) Interleukin-17 Facilitates the Immune Suppressor Capacity of High-Grade Glioma-Derived CD4 (+) CD25 (+) Foxp3 (+) T Cells Via Releasing Transforming Growth Factor Beta. Scandinavian Journal of Immunology 80:2, pages 144-150.
Crossref
Fatemeh Tabatabaie, Mehdi Mahdavi, Sobhan Faezi, Abdolhossein Dalimi, Zohreh Sharifi, Lame Akhlaghi & Fatemeh Ghaffarifar. (2014) Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines. Jundishapur Journal of Microbiology 7:2.
Crossref
Mayer Fishman. 2014. Cancer Vaccines. Cancer Vaccines 543 553 .
Hidekazu Shirota & Dennis M. Klinman. 2014. Cancer Vaccines. Cancer Vaccines 337 344 .
Shi-Ying Liu, Wei Wei, Hua Yue, De-Zhi Ni, Zhan-Guo Yue, Shuang Wang, Qiang Fu, Yue-Qi Wang, Guang-Hui Ma & Zhi-Guo Su. (2013) Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy. Biomaterials 34:33, pages 8291-8300.
Crossref
D Reyes, L Salazar, E Espinoza, C Pereda, E Castellón, R Valdevenito, C Huidobro, M Inés Becker, A Lladser, M N López & F Salazar-Onfray. (2013) Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients. British Journal of Cancer 109:6, pages 1488-1497.
Crossref
David P. Conrad, Jovian Tsang, Meaghan Maclean, Jean-Simon Diallo, Fabrice Le Boeuf, Chantal G. Lemay, Theresa J. Falls, Kelley A. Parato, John C. Bell & Harold L. Atkins. (2013) Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia. Clinical Cancer Research 19:14, pages 3832-3843.
Crossref
C.J. Rodriguez-Hernandez, M. Llorens-Agost, J. Calbó, J.R. Murguia & J.J. Guinovart. (2013) Sodium tungstate modulates ATM function upon DNA damage. FEBS Letters 587:10, pages 1579-1586.
Crossref
Puneeth Iyengar & David E. Gerber. (2013) Locally Advanced Lung Cancer. The Cancer Journal 19:3, pages 247-262.
Crossref
A.L. Silva, R.A. Rosalia, A. Sazak, M.G. Carstens, F. Ossendorp, J. Oostendorp & W. Jiskoot. (2013) Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation. European Journal of Pharmaceutics and Biopharmaceutics 83:3, pages 338-345.
Crossref
Marion Braun, Rachel Perret, Godehard Scholz & Pedro Romero. 2013. Cancer Immunotherapy. Cancer Immunotherapy 111 146 .
Neil L Berinstein, Mohan Karkada, Michael A Morse, John J Nemunaitis, Gurkamal Chatta, Howard Kaufman, Kunle Odunsi, Rita Nigam, Leeladhar Sammatur, Lisa D MacDonald, Genevieve M Weir, Marianne M Stanford & Marc Mansour. (2012) First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine 10:1.
Crossref
Janos L Tanyi & Christina S Chu. (2012) Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review. Immunotherapy 4:10, pages 995-1009.
Crossref
Chang-Cheng Liu & Xin-Shan Ye. (2012) Carbohydrate-based cancer vaccines: target cancer with sugar bullets. Glycoconjugate Journal 29:5-6, pages 259-271.
Crossref
Lukas Baitsch, Silvia A. Fuertes-Marraco, Amandine Legat, Christiane Meyer & Daniel E. Speiser. (2012) The three main stumbling blocks for anticancer T cells. Trends in Immunology 33:7, pages 364-372.
Crossref
Michael Linnebacher, Claudia Maletzki, Ulrike Klier & Ernst Klar. (2011) Bacterial immunotherapy of gastrointestinal tumors. Langenbeck's Archives of Surgery 397:4, pages 557-568.
Crossref
Michael Kalos. (2011) Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses. Cancer Immunology, Immunotherapy 61:1, pages 127-135.
Crossref
Rino Rappuoli & Ennio De GregorioJean Haensler. 2011. Novel Immunologic Adjuvants. Novel Immunologic Adjuvants 28 40 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.